Startup Biomotion: 3D bioprinting to create human tissue

Biomotion Technologies is shaping the future of industrial biofabrication with its latest 3D bioprinting system. UAS Technikum Wien welcomes the startup to the Entrepreneurship in Technology program. The new partners will move into premises at Technikum and collaborate on content with the Life Science Engineering faculty.

The company’s focus is on automation and reliability to pave the way for consistent biofabrication of human tissue. Biomotion ensures standardized and repeatable manufacturing of human tissues and implants with 3D bioprinting systems and is a manufacturer of 3D bioprinting systems that enable highly reproducible manufacturing of tissues and implants. Their patented, in-line, sterile, non-destructive (bio)-print monitoring and automatic correction process plays a critical role in autonomous (and therefore scalable) manufacturing of the medical devices of the future.

Collaboration with Cell Technologies and Biomaterials area of expertise

Biomotion is already a successful participant in the INITS Scaleup Program and #GlaubanDich Challenge winner 2023 and is looking forward to collaborating with the Cell Technologies and Biomaterials competence field of the Faculty of Life Sciences Engineering at UAS Technikum Wien.

Andreas Teuschl-Woller (Head of Master Tissue Engineering & Regenerative Medicine, UAS Technikum Wien) acts as mentor and contact person for the startup and is a tissue engineering expert at FHTW. Together, Biomotion and UAS Technikum Wien aim to significantly influence the landscape of medical research and healthcare.

Pictured, from left to right: Rafael Rasinger and Andreas Teuschl-Woller (both UAS Technikum Wien), and Gregor Weisgrab and Diego Castañeda Garay (both Biomotion), in front of their premises at UAS Technikum Wien.

Further links:

Biomotion Technologies

INITS ScaleUp

Entrepreneurship in Technology of UAS Technikum Wien